State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
Atrial fibrillation (AF) and hypertrophic cardiomyopathy (HCM) are two very common clinical entities, which often occur simultaneously, giving a hard time to both patients and cardiologists. Myocyte hypertrophy, myocyte disarray and interstitial fibrosis in the left atrium (LA) predisposes to atrial...
Main Authors: | Diego Penela, Antonio Sorgente, Riccardo Cappato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/14/3025 |
Similar Items
-
Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021-05-01) -
Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
by: Hiroki Ikenaga, MD, et al.
Published: (2017-08-01) -
The current approach of atrial fibrillation management
by: Anish Amin, et al.
Published: (2016-01-01) -
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation
by: Thomas D, et al.
Published: (2011-03-01) -
Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)